+1 877 560 8035
info@melanomanetwork.ca
French
English
Facebook
Twitter
YouTube
Flickr
Instagram
About Melanoma
What is Melanoma?
Melanoma Stats and Facts 2017
How to Prevent and Detect Melanoma
Melanoma Risk Factors
Types of Melanoma
Non-Melanoma Skin Cancer
Sun Safety
Sun Safety
Sun Myths
Top 10 Sun Safety Myths Quiz
Tanning Beds
Winter Sun Awareness
Sunscreen Information
IPSOS Sun Safety Survey
Sunscreen Information
Patient Stories
News & Events
Blog
Fundraising Events
Cover Up for Melanoma Gala
Fundraising Third Party Events
Strides for Melanoma a Walk for Awareness
Find a Location
Why I Walk – Strides Stories
Strides for Melanoma Social Media Centre
Tee off for Melanoma Awareness 2018
Calendar of Events
Uveal Melanoma Webinar
Melanoma Information Sessions
Melanoma Information Session Charlottetown PEI
Melanoma Videos Information Session Video Library
Melanoma Support Groups
Calgary Melanoma Support Group
Oshawa Melanoma Support Group
Oakville Melanoma Support Group
Melanoma Newsletter – Melanoma Patient Connection
#NotJustSkinCancer
MNC Videos
Patient Resources
Skin Biopsy
Diagnosing Melanoma – Pathology Report
Surgical tests prior to final staging – Melanoma Biopsys
Melanoma Diagnostic Tests
Staging Melanoma
Stages 0 – IV
Melanoma Recurrence
Finding the Right Doctor
Questions to Ask Your Doctor
Lymphedema for the Melanoma Patient
MNC Publications
MNC Publications
Melanoma Newsletter – Melanoma Patient Connection
Other Publications
Melanoma Videos Information Session Video Library
Glossary of Terms
Treatment & Support
MNC Support Services
Peer to Peer Melanoma Support Program
Melanoma Phone and Email Support
Melanoma Support Groups
Oshawa Melanoma Support Group
Calgary Melanoma Support Group
Oakville Melanoma Support Group
Support Group Links
Melanoma Information Sessions
Caregiver Resources
Melanoma Patient Stories
Treating Melanoma
Surgery
Chemotherapy
Radiation
Immunotherapies
Ipilimumab (Yervoy)
Pembrolizumab (Keytruda)
Nivolumab (Opdivo)
Targeted Therapy
cobimetinib (Cotellic) + vemurafenib (Zelboraf)
dabrafenib (Tafinlar) + trametinib (Mekinist)
Melanoma Drug Therapies in Canada
dabrafenib (Tafinlar) + trametinib (Mekinist)
cobimetinib (Cotellic) + vemurafenib (Zelboraf)
Ipilimumab (Yervoy)
Pembrolizumab (Keytruda)
Nivolumab (Opdivo)
Dabrafenib (Tafinlar)
nivolumab (Opdivo) + ipilimumab (Yervoy)
Trametinib (Mekinist)
Vemurafenib (Zelboraf)
Adjuvant Therapy
Clinical Trials
Questions to Ask Your Doctor
Melanoma Treatment Centres and Practitioners
Dealing with A Diagnosis
Managing Life with Melanoma
Discussion Forum
About MNC
About the Melanoma Network of Canada
Screen Me Sun Aware Camp Program
MNC Board of Directors
DONATE
Your Donations in Action
MNC Corporate Partners
Volunteer
Contact Us
DONATE
Personal Giving
In Memory & In Honor Donation
Legacy Giving
Corporate Giving
MNC Corporate Partners
Your Donations in Action
Adjuvant Therapy
Viewing topic 1 (of 1 total)
Topic
Voices
Posts
Freshness
Drug Approval Updates and News
Started by:
Melanoma Network of Canada
2
2
2 weeks, 2 days ago
bethharte
Viewing topic 1 (of 1 total)
You must be logged in to create new topics.
